Carmell Therapeutics Corporation Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| UBS OCONNOR LLC | 05/15/2025 | 371.25 K | $13.37 K | 0.00% | 1.78% |
| LINDEN ADVISORS LP | 05/15/2025 | 371.25 K | $13.37 K | 0.00% | 1.78% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 342.71 K | $12.34 K | 0.00% | 1.64% |
| SCULPTOR CAPITAL LP | 05/15/2025 | 228.30 K | $8.22 K | 0.00% | 1.09% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 188.54 K | $4.26 K | 0.00% | 0.90% |
| AQR ARBITRAGE LLC | 05/15/2025 | 61.13 K | $1.52 K | -17.82% | 0.29% |
| CITADEL ADVISORS LLC | 05/15/2025 | 45.77 K | $1.14 K | -2.28% | 0.22% |
| SABA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 19.60 K | $706 | 0.00% | 0.09% |
| CLEAR STREET LLC | 05/15/2025 | 13.50 K | $305 | 0.75% | 0.06% |
| UBS GROUP AG | 05/13/2025 | 12.69 K | $279 | 10,836.21% | 0.06% |
| ANCORA ADVISORS, LLC | 05/15/2025 | 2.79 K | $100 | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 200 | $4 | 100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| EXOS ASSET MANAGEMENT LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Carmell Therapeutics Corporation institutional Ownership - FAQ's
During the previous two years, 2 institutional investors and hedge funds held shares of Carmell Therapeutics Corporation. The most heavily invested institutionals were:
Exos Asset Management LLC: 0
Exos TFP Holdings LLC: 130,241
7.03% of Carmell Therapeutics Corporation stock is owned by institutional investors.
Institutional investors have bought a total of 130.24 K shares in the last 24 months. This purchase volume represents approximately $3.91 K in transactions.